Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations

PaperCitations, authors & open-access status

Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 37 citations, 2020 year and gold oa status.

37
Citations
2020
Year
gold
OA Status

Related on ScholarIQ

Scott L. Wexelblatt
Author
Prenatal Substance Exposure Effects
Topic
Prenatal Substance Exposure Effects
Topic
Maternal Mental Health During Pregnancy and Postpartum
Topic
Opioid Use Disorder Treatment
Topic
470M+ articles · free account